Member Exclusive News

Heart-on-a-chip replicates human drug response: is this the future of cardiac drug development?

An engineered heart-on-a-chip system, developed by TARA Biosystems (NY, USA) and GlaxoSmithKline (London, UK), has been found to reproduce the human heart’s response to known drugs – providing a ground-breaking method for cardiac drug screening.

Aug 07, 2019
0
0

Please sign in or register for FREE

No comments yet.